Fully funded PhD studentships announced at the Institute of Cancer Therapeutics
Published on 11/04/2019
Focused on the generation of new anticancer prodrugs, the ICT-DTC has been created following a major £2m investment by ICT spin-out company Incanthera Ltd. We are now looking for applications from outstanding potential PhD candidates.
Project 1: Novel targeted cytotoxic chemotherapy for prostate cancer
Project 2: Novel targeted cytotoxic chemotherapy for colorectal cancer
Project 3: Novel prodrug anti-metastatic therapy for neuroblastoma
For more information on individual projects and how to apply please visit www.bradford.ac.uk/ict/doctoral-training
